Prostate cancer: Defining biochemical failure in patients treated with HIFU

Nature Reviews Urology

Volumn 7, Issue 4, 2010, Pages 186-187

  Abdel Wahab, May ^a   Pollack, Alan ^a  

^a UNIVERSITY OF MIAMI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANDROGEN; PROSTATE SPECIFIC ANTIGEN;

ACCURACY; BIOCHEMISTRY; BONE METASTASIS; BRACHYTHERAPY; CANCER RADIOTHERAPY; CRYOSURGERY; EXTERNAL BEAM RADIOTHERAPY; HIGH INTENSITY FOCUSED ULTRASOUND; HORMONAL THERAPY; HUMAN; LYMPH NODE METASTASIS; MEDICAL DECISION MAKING; MEDICAL SOCIETY; MINIMALLY INVASIVE PROCEDURE; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; SENSITIVITY AND SPECIFICITY; SHORT SURVEY; TREATMENT FAILURE; TREATMENT RESPONSE; UNITED STATES;

BIOLOGICAL MARKERS; HUMANS; MALE; PREDICTIVE VALUE OF TESTS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; ULTRASOUND, HIGH-INTENSITY FOCUSED, TRANSRECTAL;

EID: 77950990461     PISSN: 17594812     EISSN: 17594820     Source Type: Journal    
DOI: 10.1038/nrurol.2010.12     Document Type: Short Survey

References (9)

1. Chavrier, F. et al. Modeling of HiFU induced lesions in the presence of cavitation bubbles. J. Acoust. Soc. Am. 108, 432-440 (2000).
2. Poissonnier, L. et al. Control of prostate cancer by transrectal HiFU in 227 patients. Eur. Urol. 51, 381-387 (2007). (Pubitemid 44937777)
3. Gelet, A. et al. Transrectal high intensity focused ultrasound for the treatment of localised prostate cancer: factors influencing the outcome. Eur. Urol. 40, 124-129 (2001). (Pubitemid 32786096)
4. Thüroff, s. et al. High intensity focused ultrasound and localized prostate cancer: efficacy results from the european multicentric study. J. Endourol. 17, 673-677 (2003). (Pubitemid 37362918)
5. Chaussy, C. & Thüroff, s. The status of highintensity focused ultrasound in the treatment of localized prostate cancer and the impact of a combined resection. Curr. Urol. Rep. 4, 248-252 (2003).
6. Blana, A. et al. eight years' experience with high-intensity focused ultrasonography for treatment of localized prostate cancer. Urology 72, 1329-1333 (2008).
7. Ganzer, R. et al. PsA nadir is a significant predictor of treatment failure after highintensity focused ultrasound (HiFU) treatment of localised prostate cancer. Eur. Urol. 53, 547-553 (2008).
8. Blana, A. et al. High-intensity focused ultrasound for prostate cancer: comparative definitions of biochemical failure. BJU Int. 104, 1058-1062 (2009).
9. Roach, M. iii et al. Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-AsTRO Phoenix Consensus Conference. Int. J. Radiat. Oncol. Biol. Phys. 65, 965-974 (2006). (Pubitemid 43914244)